These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Hajiramezanali M; Atyabi F; Mosayebnia M; Akhlaghi M; Geramifar P; Jalilian AR; Mazidi SM; Yousefnia H; Shahhosseini S; Beiki D Int J Nanomedicine; 2019; 14():2591-2605. PubMed ID: 31040674 [TBL] [Abstract][Full Text] [Related]
3. Gastrin-releasing peptide receptor-targeted gadolinium oxide-based multifunctional nanoparticles for dual magnetic resonance/fluorescent molecular imaging of prostate cancer. Cui D; Lu X; Yan C; Liu X; Hou M; Xia Q; Xu Y; Liu R Int J Nanomedicine; 2017; 12():6787-6797. PubMed ID: 28979118 [TBL] [Abstract][Full Text] [Related]
4. Preclinical and first clinical experience with the gastrin-releasing peptide receptor-antagonist [⁶⁸Ga]SB3 and PET/CT. Maina T; Bergsma H; Kulkarni HR; Mueller D; Charalambidis D; Krenning EP; Nock BA; de Jong M; Baum RP Eur J Nucl Med Mol Imaging; 2016 May; 43(5):964-973. PubMed ID: 26631238 [TBL] [Abstract][Full Text] [Related]
5. Gold nanorods-bombesin conjugate as a potential targeted imaging agent for detection of breast cancer. Heidari Z; Sariri R; Salouti M J Photochem Photobiol B; 2014 Jan; 130():40-6. PubMed ID: 24300991 [TBL] [Abstract][Full Text] [Related]
6. A new (68)Ga-labeled BBN peptide with a hydrophilic linker for GRPR-targeted tumor imaging. Pan D; Xu YP; Yang RH; Wang L; Chen F; Luo S; Yang M; Yan Y Amino Acids; 2014 Jun; 46(6):1481-9. PubMed ID: 24633452 [TBL] [Abstract][Full Text] [Related]
7. Synthesis and characterization of Bombesin-superparamagnetic iron oxide nanoparticles as a targeted contrast agent for imaging of breast cancer using MRI. Jafari A; Salouti M; Shayesteh SF; Heidari Z; Rajabi AB; Boustani K; Nahardani A Nanotechnology; 2015 Feb; 26(7):075101. PubMed ID: 25642737 [TBL] [Abstract][Full Text] [Related]
8. Novel radiolabeled peptides for breast and prostate tumor PET imaging: (64)Cu/and (68)Ga/NOTA-PEG-[D-Tyr(6),βAla(11),Thi(13),Nle(14)]BBN(6-14). Fournier P; Dumulon-Perreault V; Ait-Mohand S; Tremblay S; Bénard F; Lecomte R; Guérin B Bioconjug Chem; 2012 Aug; 23(8):1687-93. PubMed ID: 22770480 [TBL] [Abstract][Full Text] [Related]
9. Preclinical comparison of Al18F- and 68Ga-labeled gastrin-releasing peptide receptor antagonists for PET imaging of prostate cancer. Chatalic KL; Franssen GM; van Weerden WM; McBride WJ; Laverman P; de Blois E; Hajjaj B; Brunel L; Goldenberg DM; Fehrentz JA; Martinez J; Boerman OC; de Jong M J Nucl Med; 2014 Dec; 55(12):2050-6. PubMed ID: 25413139 [TBL] [Abstract][Full Text] [Related]
10. 68Ga-NOTA-Aca-BBN(7-14) PET/CT in Healthy Volunteers and Glioma Patients. Zhang J; Li D; Lang L; Zhu Z; Wang L; Wu P; Niu G; Li F; Chen X J Nucl Med; 2016 Jan; 57(1):9-14. PubMed ID: 26449838 [TBL] [Abstract][Full Text] [Related]
11. Zhang J; Mao F; Niu G; Peng L; Lang L; Li F; Ying H; Wu H; Pan B; Zhu Z; Chen X Theranostics; 2018; 8(4):1121-1130. PubMed ID: 29464003 [No Abstract] [Full Text] [Related]
12. Preclinical Evaluation of NHS-Activated Gold Nanoparticles Functionalized with Bombesin or Neurotensin-Like Peptides for Targeting Colon and Prostate Tumours. Chilug LE; Niculae D; Leonte RA; Nan A; Turcu R; Mustaciosu C; Serban RM; Lavric V; Manda G Molecules; 2020 Jul; 25(15):. PubMed ID: 32722221 [TBL] [Abstract][Full Text] [Related]
13. Synthesis and radiopharmacological evaluation of a high-affinity and metabolically stabilized 18F-labeled bombesin analogue for molecular imaging of gastrin-releasing peptide receptor-expressing prostate cancer. Richter S; Wuest M; Krieger SS; Rogers BE; Friebe M; Bergmann R; Wuest F Nucl Med Biol; 2013 Nov; 40(8):1025-34. PubMed ID: 23969085 [TBL] [Abstract][Full Text] [Related]
14. Dual-Modality Imaging of Prostate Cancer with a Fluorescent and Radiogallium-Labeled Gastrin-Releasing Peptide Receptor Antagonist. Zhang H; Desai P; Koike Y; Houghton J; Carlin S; Tandon N; Touijer K; Weber WA J Nucl Med; 2017 Jan; 58(1):29-35. PubMed ID: 27516447 [TBL] [Abstract][Full Text] [Related]
16. Positron Emission Tomography Imaging of Prostate Cancer with Ga-68-Labeled Gastrin-Releasing Peptide Receptor Agonist BBN Cheng S; Lang L; Wang Z; Jacobson O; Yung B; Zhu G; Gu D; Ma Y; Zhu X; Niu G; Chen X Bioconjug Chem; 2018 Feb; 29(2):410-419. PubMed ID: 29254329 [TBL] [Abstract][Full Text] [Related]
17. Zhang J; Tian Y; Li D; Niu G; Lang L; Li F; Liu Y; Zhu Z; Chen X Eur J Nucl Med Mol Imaging; 2019 Sep; 46(10):2152-2162. PubMed ID: 31270559 [TBL] [Abstract][Full Text] [Related]
18. Clinical Translation of a Dual Integrin αvβ3- and Gastrin-Releasing Peptide Receptor-Targeting PET Radiotracer, 68Ga-BBN-RGD. Zhang J; Niu G; Lang L; Li F; Fan X; Yan X; Yao S; Yan W; Huo L; Chen L; Li Z; Zhu Z; Chen X J Nucl Med; 2017 Feb; 58(2):228-234. PubMed ID: 27493267 [TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo analysis of [(64)Cu-NO2A-8-Aoc-BBN(7-14)NH(2)]: a site-directed radiopharmaceutical for positron-emission tomography imaging of T-47D human breast cancer tumors. Prasanphanich AF; Retzloff L; Lane SR; Nanda PK; Sieckman GL; Rold TL; Ma L; Figueroa SD; Sublett SV; Hoffman TJ; Smith CJ Nucl Med Biol; 2009 Feb; 36(2):171-81. PubMed ID: 19217529 [TBL] [Abstract][Full Text] [Related]
20. PET of tumors expressing gastrin-releasing peptide receptor with an 18F-labeled bombesin analog. Dijkgraaf I; Franssen GM; McBride WJ; D'Souza CA; Laverman P; Smith CJ; Goldenberg DM; Oyen WJ; Boerman OC J Nucl Med; 2012 Jun; 53(6):947-52. PubMed ID: 22570329 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]